Post Marketing Surveillance Study of Cuprimine
Cuprimine (penicillamine) was made available in the Philippines by the Sponsor under a Compassionate Special Permit issued by the Bureau of Food and Drugs. Physicians were able to request the drug for their patients from the Sponsor. A Clinical Study Report form was completed for each purchase of Cuprimine.
|Study Type:||Expanded Access What is Expanded Access?|
|Official Title:||Post Marketing Surveillance Study of Cuprimine (MK-0172-001)|